Editorial: Drugs for gastric ulceration.
D001729:Bismuth / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006035:Glycyrrhiza; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D010437:Peptic Ulcer / Q000188:drug therapy*; D010946:Plants, Medicinal; D012907:Smoking; D013148:Spironolactone / Q000494:pharmacology; D013185:Squalene / Q000627:therapeutic use; D013729:Terpenes / Q000009:adverse effects / Q000627:therapeutic use*
D013729:Terpenes; D002792:Cholestyramine Resin; D013148:Spironolactone; D004054:Diethylstilbestrol; D013185:Squalene; D001729:Bismuth